Handbook of Therapeutic Antibodies, Band 3

Frontcover
Stefan Dübel
Wiley-VCH, 2007 - 1188 Seiten
0 Rezensionen
In this most comprehensive reference source for the development, production and therapeutic application of antibodies, Volume I contains general chapters presenting established technologies and clinical applications. Volume II provides a look at emerging technologies, new therapeutic concepts, and clinical studies. The third volume features detailed and specific information about each currently approved type of antibody, including the clinical data.
A must-have resource for academic researchers, decision makers in industry and healthcare professionals in the clinic.

Was andere dazu sagen - Rezension schreiben

Es wurden keine Rezensionen gefunden.

Ähnliche Bücher

Referenzen von Webseiten

Wiley-VCH - Dübel, Stefan (ed.) - Handbook of Therapeutic Antibodies
Handbook of Therapeutic Antibodies. 1. Edition - January 2007 499.- Euro 2007. XXXVIII, 1190 Pages, 3 Volumes, Hardcover - Handbook/Reference Book - ...
www.wiley-vch.de/ publish/ en/ books/ ISBN3-527-31453-9

Handbook of Therapeutic Antibodies Immunology
NEUE BÜCHER. © 2007 Wiley-VCH Verlag gmbh & Co. kgaa, Weinheim. www.pharmuz.de. 5/2007 (36). |. Pharm. Unserer Zeit. |. 407. Handbook of. Therapeutic ...
doi.wiley.com/ 10.1002/ pauz.200790088

Alfacell's Onconase Highlighted in Latest Edition of Handbook of ...
The Handbook of Therapeutic Antibodies (ed: Stephen Dubel;published b...About ONCONASE(R) ...ONCONASE is a first-in-class therapeutic based on ...
www.bio-medicine.org/ medicine-technology/ Alfacells-Onconase-Highlighted-in-Latest-Edition-of-Handbook-of-0ATherapeut...

Handbook of Therapeutic Antibodies Edited by Stefan Dübel
Handbook of Therapeutic Antibodies. Volume I. Edited by. Stefan Dübel ... Handbook of Therapeutic Antibodies. Edited by Stefan Dübel ...
doi.wiley.com/ 10.1002/ 9783527619740.fmatter

ABC 7 - Chicago
The Handbook of Therapeutic Antibodies (ed: Stephen Dubel; published by Wiley VCH March 2007) presents an up-to-date and comprehensive review for the ...
finance.abc7chicago.com/ abclocal?Account=wls& GUID=1495980& Page=MediaViewer& Ticker=ACEL

Wiley-VCH - Dübel, Stefan (ed.) - Handbook of Therapeutic Antibodies
Handbook of Therapeutic Antibodies. 1. Auflage - Januar 2007 499,- Euro 2007. XXXVIII, 1190 Seiten, 3 Bände, Hardcover - Handbuch/Nachschlagewerk - ...
www.wiley-vch.de/ publish/ dt/ books/ ISBN3-527-31453-9

Handbook of Therapeutic Antibodies
Handbook of Therapeutic Antibodies - Wiley - 3527314539 - 2007.
www.libreriasaulamedica.com/ ficha.asp?fam=1& id=28811& subcat=Biotecnolog%EDa

livre handbook of therapeutic antibodies (3 volume), bio ...
livre bio-informatique et biotechnologie et technologie pharmaceutique : in this most comprehensive reference source for the development, production and ...
www.lavoisier.fr/ notice/ fr416728.html

Handbook of Therapeutic Antibodies - egymedicine.com
Handbook of Therapeutic Antibodies By Stefan Dübel Publisher: Wiley-VCH Number Of Pages: 1228 Publication Date: 2007-03-26 ISBN-10 / ASIN: 3527314539 ...
www.egymedicine.com/ forums/ t17165.html

[Frontiers in Bioscience 13, 1619-1633, January 1, 2008]
In: Handbook of therapeutic antibodies. Ed: Dubel S. Wiley-VCH, Weinheim (2007). 3. Hwang, wy & J. Foote: Immunogenicity of engineered antibodies. ...
www.bioscience.org/ 2008/ v13/ af/ 2786/ 2.asp

Über den Autor (2007)

Stefan Dübel got his PhD at the Center for Molecular Biology Heidelberg (ZMBH) and spent his post-doc at the German Cancer Research Center (DKFZ) with research on the development of antibody display libraries. In the following years, he substantially participated in the invention of recombinant antibody phage display technology, as well as other recombinant antibody technologies and the development of various antibody fusion proteins. In 1996, he moved to the University of Heidelberg to establish the antibody engineering group at the Institute of Molecular Genetics. After holding a group leader position at the University of Heidelberg from 1996, Stefan Dübel went to the Biological Faculty of the Technical University of Braunschweig as a full professor in 2002. Here, he currently serves as head of the Department of Biotechnology in Braunschweig and managing director of the Institute of Biochemistry and Biotechnology. He has co-authored more than 90 scientific papers, 17 patents, as well as two acknowledged textbooks in the field of recombinant antibodies. He is also board member of scientific journals and the biotech industry.

Bibliografische Informationen